Erratum to: Diabetol Int DOI 10.1007/s13340-017-0330-2
In the original publication of the article, a percentage symbol has been included incorrectly in the value of Alcohol consumption (65–74 years) as 45.1% in Table 1. The correct version is published with this erratum.
Table 1.
Comparison of patient characteristics between the elderly and non-elderly patients
| ≥ 75 years (n = 130) | 65–74 years (n = 189) | < 65 years (n = 332) | p | ||||
|---|---|---|---|---|---|---|---|
| n | Mean ± SD or % | n | Mean ± SD or % | n | Mean ± SD or % | ||
| Age (years) | 130 | 80.0 ± 4.7 | 189 | 69.2 ± 2.9 | 332 | 54.5 ± 7.4 | 0.000* |
| Height (cm) | 127 | 156.2 ± 9.6 | 187 | 161.0 ± 8.6 | 328 | 166.2 ± 8.8 | 0.000* |
| Waist circumference (cm) | 80 | 85.7 ± 10.5 | 120 | 87.3 ± 9.6 | 193 | 89.9 ± 12.0 | 0.009* |
| Duration of diabetes (days) | 111 | 121.4 ± 94.6 | 181 | 114.1 ± 78.4 | 308 | 95.4 ± 74.4 | 0.003* |
| Sex (male) | 67 | 51.5 | 117 | 61.9 | 250 | 75.3 | 0.000* |
| Smoking | 13 | 10.3 | 34 | 18.6 | 96 | 29.8 | 0.000* |
| Alcohol consumption | 39 | 31.7 | 82 | 45.1 | 180 | 56.1 | 0.000* |
| Retinopathy | 8 | 6.2 | 8 | 4.2 | 32 | 9.6 | 0.064 |
| Arteriosclerosis obliterans | 6 | 4.6 | 21 | 11.1 | 28 | 8.4 | 0.122 |
| Stroke | 0 | 0.0 | 1 | 0.6 | 0 | 0.0 | 0.288 |
| Myocardial infarction | 7 | 5.4 | 5 | 2.6 | 6 | 1.8 | 0.108 |
| Angina pectoris | 8 | 6.2 | 8 | 4.2 | 11 | 3.3 | 0.387 |
| Cardiac failure | 5 | 3.8 | 2 | 1.1 | 4 | 1.2 | 0.102 |
| Atrial fibrillation | 4 | 3.1 | 5 | 2.6 | 7 | 2.1 | 0.817 |
| Diet/exercise therapy | 49 | 37.7 | 48 | 25.4 | 92 | 27.7 | 0.044* |
| Low dose of glimepiride | 18 | 13.8 | 25 | 13.2 | 29 | 8.7 | 0.153 |
| Medium dose of glimepiride | 9 | 6.9 | 21 | 11.1 | 20 | 6.0 | 0.104 |
| BG | 9 | 6.9 | 25 | 13.2 | 65 | 19.6 | 0.002* |
| TZD | 7 | 5.4 | 12 | 6.3 | 19 | 5.7 | 0.929 |
| α-GI | 5 | 3.8 | 3 | 1.6 | 10 | 3.0 | 0.446 |
| Multidrug therapy | 33 | 25.4 | 55 | 29.1 | 97 | 29.2 | 0.692 |
| Antihypertensive drug | 81 | 62.3 | 106 | 56.1 | 144 | 43.4 | 0.000* |
| Antihyperlipidemic drug | 62 | 47.7 | 94 | 49.7 | 156 | 47.0 | 0.832 |
| Antihyperuricemic drug | 6 | 4.6 | 9 | 4.8 | 16 | 4.8 | 0.996 |
| Antithrombogenic drug | 22 | 16.9 | 44 | 23.3 | 52 | 15.7 | 0.088 |
* p < 0.05
Footnotes
The online version of the original article can be found under doi:10.1007/s13340-017-0330-2.
Contributor Information
Noriko Ujihara, Phone: +81-3-3499-1911, Email: ujihara.noriko@twmu.ac.jp.
for the JAMP Study Investigators:
Akiko Sato, Akira Miyashita, Asako Kokubo, Atsuro Tsuchiya, Dai Hirohara, Daiji Kogure, Daijo Kasahara, Hideki Tanaka, Hideki Tanaka, Hideo Tezuka, Hiroyuki Kuroki, Jun Ogino, Kanu Kin, Kanu Kin, Kazuko Muto, Kazuo Suzuki, Keiko Iseki, Keita Watanabe, Kenshi Higami, Kenzo Matsumura, Kiyotaka Nakajima, Koki Shin, Kuniya Koizumi, Maki Saneshige, Makio Sekine, Makoto Yaida, Mari Kiuchi, Mari Mugishima, Mari Osawa, Masae Banno, Masahiro Yamamoto, Masatake Hiratsuka, Masumi Hosoya, Michika Atsuta, Mitsutoshi Kato, Miwa Morita, Munehiro Miyamae, Mutsumi Iijima, Naomi Okuyama, Nobuo Hisano, Norihiro Tsuchiya, Rie Wada, Rie Wada, Ryuji Momose, Sachiko Otake, Satoko Maruyama, Satoru Takada, Shigeki Dan, Shigeki Nishizawa, Shigeo Yamashita, Shingo Saneshige, Shinichi Teno, Shinji Tsuruta, Shinobu Kumakura, Sumiko Kijima, Takashi Kondo, Takeo Onishi, Taku Kudo, Tatsushi Sugiura, Toshihiko Ishiguro, Yasue Suzuki, Yasuhiro Tomita, Yasuko Takano, Yoshihisa Akimoto, Yoshiko Odanaka, Yoshimasa Tasaka, Yoshitaka Aiso, Yukiko Inoue, and Yukinobu Kobayashi